Aesica Pharmaceuticals

Aesica Pharmaceuticals

Signal active

Organization

Contact Information

Overview

Aesica Pharmaceuticals Ltd. develops, manufactures, and supplies active pharmaceutical ingredients, formulations, and custom synthesis solutions to biotechnology organizations, pharmaceuticals, and generic manufacturers. It offers contract manufacturing services for various formulated products, including anti-Infective, cardiovascular, anti-viral, anesthetics, anti-inflammatory, haemostatic, hormones, and potent drugs. The company was founded in 2004 and is headquartered in Newcastle upon Tyne, the United Kingdom with additional offices in Tyne and Wear, Cramlington, Ponders End, Queenborough, New Jersey, and Shanghai. Aesica Pharmaceuticals Ltd. is a prior subsidiary of BASF SE.

About

Industries

Biotechnology, Manufacturing

Founded

2004

Employees

5001-10000

Headquarters locations

Europe

Social

N/A

Profile Resume

Aesica Pharmaceuticals headquartered in Europe, operates in the Biotechnology, Manufacturing sector. With a team of 5001-10000 employees, Aesica Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Private Equity Round - Aesica Pharmaceuticals, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Robert Hardy

Robert Hardy

Founder

Funding Rounds

Funding rounds

1

Investors

1

Lead Investors

0

Total Funding Amount

$0

Details

1

Aesica Pharmaceuticals has raised a total of $0 in funding over 1 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2011Private Equity

Investors

Aesica Pharmaceuticals is funded by 2 investors.

Investor NameLead InvestorFunding RoundPartners
Aesica Pharmaceuticals-FUNDING ROUND - Aesica Pharmaceuticalsundefined
Silverfleet Capital-FUNDING ROUND - Silverfleet Capitalundefined

Recent Activity

There is no recent news or activity for this profile.